RTS, S/AS01 malaria vaccine and child mortality

The Lancet

Volumn 386, Issue 10005, 2015, Pages 1736-

  Müller, Olaf ^a   Tozan, Yesim ^b   Becher, Heiko ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; RTS,S AS01 VACCINE; UNCLASSIFIED DRUG; VACCINE;

CHILDHOOD MORTALITY; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; HUMAN; LETTER; MALARIA; MORBIDITY; PRIORITY JOURNAL; VACCINATION; FEMALE; MALARIA, FALCIPARUM; MALE;

FEMALE; HUMANS; MALARIA; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; VACCINES;

EID: 84946059751     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00694-7     Document Type: Letter

References (5)

1. RTS,S Clinical Trials Partnership Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 386 2015 31 45
2. The Lancet Vaccines: a step change in malaria prevention? Lancet 385 2015 1591
3. CS Benn, MG Netea, LK Selin, P Aaby A small jab - a big effect: nonspecific immunomodulation by vaccines Trends Immunol 34 2013 431 439
4. KL Flanagan, R van Crevel, N Curtis, F Shann, O Levy Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms Clin Infect Dis 57 2013 283 289
5. V Louis, J Bals, J Tiendrebéogo et al. Long-term effects of malaria prevention with insecticide-treated mosquito nets on morbidity and mortality in African children: randomised controlled trial Trop Med Int Health 17 2012 733 741